Majid Vakilynejad

Majid Vakilynejad

Takeda Pharmaceutical Company Limited - Osaka / Japan
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4405977
武田薬品工業株式会社
person_outline Majid Vakilynejad's MOST POPULAR ARTICLES
1-) dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy Alimentary pharmacology & therapeutics 29 (9), 928-937, 2009
2-) Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled … Current medical research and opinion 25 (3), 627-638, 2009
3-) Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of the GPR40 agonist TAK‐875: results from a double‐blind, placebo‐controlled single oral dose rising … The Journal of Clinical Pharmacology 52 (7), 1007-1016, 2012
4-) Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs Clinical pharmacokinetics 41, 533-558, 2002
5-) Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugsR Mehvar, DR Brocks, M VakilyClinical pharmacokinetics 41, 533-558, 2002982002